ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) Total liabilities 2018–2025
ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT) total liabilities at each fiscal year-end, per SEC filings.
$287.7MFY2025 · since FY2018: $29.9M → $287.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $287.7M | -14.6% |
| FY2024 | $336.9M | -4.5% |
| FY2023 | $352.9M | -10.1% |
| FY2022 | $392.5M | +23.0% |
| FY2021 | $319.2M | -14.4% |
| FY2020 | $373.1M | +9.3% |
| FY2019 | $341.3M | +1039.7% |
| FY2018 | $29.9M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice